UPDATE: Goldman Sachs Resumes Coverage on Health Care REIT on High-Quality Portfolio, Lower Earnings Growth
In a report published Tuesday, Goldman Sachs analyst Andrew Rosivach resumed coverage on Health Care REIT (NYSE: HCN) with a Neutral rating and $61.00 price target.
In the report, Goldman Sachs noted, “We resume coverage of Health Care REIT, Inc. (HCN) with a Neutral rating and a 12-month price target of $61 (4% total return including dividends). The price target is based on a target 2018E AFFO multiple in line with our sector average, which is warranted given the company's high-quality portfolio, but an estimated lower-than-average earnings growth.”
Health Care REIT closed on Monday at $62.81.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.